<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01512914</url>
  </required_header>
  <id_info>
    <org_study_id>AR HSG 01-2008</org_study_id>
    <nct_id>NCT01512914</nct_id>
  </id_info>
  <brief_title>Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery</brief_title>
  <official_title>Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Gerardo Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Gerardo Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studies evaluating intraperitoneal local anesthetic instillation for pain relief after
      laparoscopic procedures have provided conflicting results. This randomized, double-blind
      study was designed to assess the effects of a novel intraperitoneal local anesthetic
      administration technique using nebulization on pain relief after gynecologic laparoscopic
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies evaluating intraperitoneal local anesthetic (LA) instillation for pain relief after
      laparoscopic surgery have provided conflicting results. One of the factors that might
      contribute to failure of the instillation technique may be related to inadequate distribution
      of local anesthetic throughout the peritoneal surface. In contrast, nebulization should
      provide a uniform spread of drugs throughout the peritoneal cavity and thus may be beneficial
      to improve pain relief after laparoscopic procedures. The investigators reported that a
      microvibration-based nebulization device (Aeroneb ProÂ® system, Aerogen, Galway, Ireland)
      could be used for ropivacaine delivery into the insufflation gas required to create
      pneumorpeitoneum. The investigators hypothesized that intraperitoneal ropivacaine
      nebulization would provide superior pain relief than ropivacaine instillation after
      gynecologic laparoscopic surgery. This randomized, double blind, controlled clinical trial
      was designed to assess the analgesic efficacy of ropivacaine nebulization before or after
      surgery compared with intraperitoneal ropivacaine instillation and placebo after gynecologic
      laparoscopic procedures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>24 hours</time_frame>
    <description>Postoperative pain was assessed by NRS (0 to 10 points) at rest (static NRS) and after a deep inspiration or cough (dynamic NRS). The proportion of patients with adequate pain control after surgery (dynamic NRS &lt; 3) will also be assessed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>The total dose of morphine at every evaluation after awakening will be quantified using the PACU clinical chart and/or PCA infusers memory display</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unassisted walking time</measure>
    <time_frame>24 hours</time_frame>
    <description>Unassisted walking time is defined as the time in hours between PACU discharge and when the patient is able to walk out of his room and back to bed without any assistance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>between surgery and discharge</time_frame>
    <description>We define hospital stay as the elapsed time between surgery and hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital morbidity</measure>
    <time_frame>up to discharge</time_frame>
    <description>All complications or adverse effects associated or possibly associated with the interventions under study, surgery or anesthesia will be quantified using the anesthesia charts, surgical charts, surgical database.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Gynecologic Laparoscopic Surgery</condition>
  <arm_group>
    <arm_group_label>CONTROL group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>PREOPERATIVE nebulization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>POSTOPERATIVE nebulization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>INSTILLATION group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 30 mg</intervention_name>
    <description>preoperative instillation of saline 20 ml, nebulization of ropivacaine 1% 3 ml (30 mg) before surgery and nebulization of saline 3 ml after surgery</description>
    <arm_group_label>PREOPERATIVE nebulization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 30 mg</intervention_name>
    <description>preoperative instillation of saline 20 ml, preoperative nebulization of saline 3 ml and nebulization of ropivacaine 1% 3 ml (30 mg) after surgery</description>
    <arm_group_label>POSTOPERATIVE nebulization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 100 mg</intervention_name>
    <description>preoperative instillation of ropivacaine 0,5% 20 ml (100 mg) and nebulization of saline 3 ml before and after surgery</description>
    <arm_group_label>INSTILLATION group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>preoperative instillation of saline 20 ml and nebulization of saline before and after surgery</description>
    <arm_group_label>CONTROL group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females 18-70 years old, ASA score 1 - 3;

          -  scheduled for laparoscopic operative surgery in the Obstetrics and Gynecology unit;

          -  free from pain in preoperative period, without habitual analgesic use;

          -  without cognitive impairment or mental retardation, who gave a written informed
             consent

        Exclusion Criteria:

          -  Females under 18 or over 70;

          -  ASA 4 or 5;

          -  emergency/urgency criteria, postoperative admission in a intensive care unit with
             sedation or ventilatory assistance; cognitive impairment or mental retardation;

          -  habitual analgesic use; progressive degenerative diseases of the CNS;

          -  convulsions or chronic therapy with antiepileptic drugs;

          -  severe hepatic or renal impairment;

          -  pregnancy or lactation;

          -  allergy to one of the specific substances used in the study;

          -  acute infectious disease or inflammatory chronic disease, alcohol or drug addiction;

          -  any kind of communication problem;

          -  neurologic or psychiatric disease;

          -  no written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pablo M Ingelmo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Gerardo Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Gerardo Hospital</name>
      <address>
        <city>Monza</city>
        <state>MB</state>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Goldstein A, Grimault P, Henique A, Keller M, Fortin A, Darai E. Preventing postoperative pain by local anesthetic instillation after laparoscopic gynecologic surgery: a placebo-controlled comparison of bupivacaine and ropivacaine. Anesth Analg. 2000 Aug;91(2):403-7.</citation>
    <PMID>10910857</PMID>
  </results_reference>
  <results_reference>
    <citation>Alkhamesi NA, Peck DH, Lomax D, Darzi AW. Intraperitoneal aerosolization of bupivacaine reduces postoperative pain in laparoscopic surgery: a randomized prospective controlled double-blinded clinical trial. Surg Endosc. 2007 Apr;21(4):602-6. Epub 2006 Dec 16.</citation>
    <PMID>17180268</PMID>
  </results_reference>
  <results_reference>
    <citation>Greib N, Schlotterbeck H, Dow WA, Joshi GP, Geny B, Diemunsch PA. An evaluation of gas humidifying devices as a means of intraperitoneal local anesthetic administration for laparoscopic surgery. Anesth Analg. 2008 Aug;107(2):549-51. doi: 10.1213/ane.0b013e318176fa1c.</citation>
    <PMID>18633034</PMID>
  </results_reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2012</study_first_submitted>
  <study_first_submitted_qc>January 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2012</study_first_posted>
  <last_update_submitted>January 18, 2012</last_update_submitted>
  <last_update_submitted_qc>January 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Gerardo Hospital</investigator_affiliation>
    <investigator_full_name>Pablo Mauricio Ingelmo M.D.</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Gynecologic laparoscopic surgery</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>Nebulization</keyword>
  <keyword>Ropivacaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

